CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule

PartnershipVHH antibody moleculePositive
AI Analysis

Summary

Biocytogen Pharmaceuticals has signed a non-exclusive licensing agreement with Qilu Pharmaceutical for a fully human VHH antibody molecule.

Importance:4/10
Sentiment:
0.50
partnershiplicensingantibodyVHH

Read the original article

Published by Pharmaceutical Technology on September 3, 2026 8:54 AM

Read Original